Home > Healthcare > Medical Services > clinical trial equipment and ancillary solutions market
Get a free sample of Clinical Trial Equipment & Ancillary Solutions Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Clinical Trial Equipment & Ancillary Solutions Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market for clinical trial equipment and ancillary solutions is highly competitive, with key players vying for market share through innovation and strategic partnerships. The major companies are prioritizing comprehensive supply chain and logistics services, while startups and niche companies are enhancing competitiveness with specialized ancillary solutions and technologies, shaping a dynamic market landscape.
Some of the prominent players operating in the clinical trial equipment & ancillary solutions industry include:
North America clinical trial equipment & ancillary solutions industry size was USD 730.7 million in 2023, primarily due to its advanced healthcare infrastructure, robust research and development activities, and supportive regulatory framework.
Key players operating in the clinical trial equipment & ancillary solutions industry are Ancillare, LP., Axelerist Financial, Biocair, ICON plc, Imperial CRS, LLC, Marken, MESM UK., Myonex, Nuvisan, Oximio, Parexel International (MA) Corporation, Quipment SAS, and Thermo Fisher Scientific Inc.
Clinical trial equipment & ancillary solutions industry size recorded USD 1.5 billion in 2023 and will expand at a 7.5% CAGR between 2024 and 2032, driven by the rising complexity of clinical trials, the globalization of clinical research, and advancements in technology.
The diagnostic equipment segment in the market will reach USD 1.1 billion by 2032, owing to increasing emphasis on precision medicine and personalized healthcare.